Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kyle

Showing results (851-860 of 874) with videos related to

Pageof 88
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple MyelomaSathish Gopalakrishnan, Anita D'Souza, Emma Scott, et al.
Nature Reviews. Nephrology|December 5, 2018
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2018
Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between GroupsEmma C Scott, Parameswaran Hari, Sathish Kumar, et al.
American Journal of Hematology|October 29, 2017
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemiaJithma P Abeykoon, Jonas Paludo, Rebecca L King, et al.
Blood|July 26, 2023
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomasUdit Yadav, Shaji K Kumar, Linda B Baughn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensusP Musto, K C Anderson, M Attal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research StudyAnita D'Souza, Angela Dispenzieri, Baldeep Wirk, et al.
The Lancet. Oncology|December 3, 2014
International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaS Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, et al.
Nature Reviews. Nephrology|December 21, 2018
Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
The Lancet. Oncology|June 5, 2019
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disordersJens Hillengass, Saad Usmani, S Vincent Rajkumar, et al.
Pageof 88

Showing results (851-860 of 874) with videos related to

Sort By:
Pageof 88
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple MyelomaSathish Gopalakrishnan, Anita D'Souza, Emma Scott, et al.
Nature Reviews. Nephrology|December 5, 2018
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2018
Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between GroupsEmma C Scott, Parameswaran Hari, Sathish Kumar, et al.
American Journal of Hematology|October 29, 2017
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemiaJithma P Abeykoon, Jonas Paludo, Rebecca L King, et al.
Blood|July 26, 2023
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomasUdit Yadav, Shaji K Kumar, Linda B Baughn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensusP Musto, K C Anderson, M Attal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research StudyAnita D'Souza, Angela Dispenzieri, Baldeep Wirk, et al.
The Lancet. Oncology|December 3, 2014
International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaS Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, et al.
Nature Reviews. Nephrology|December 21, 2018
Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
The Lancet. Oncology|June 5, 2019
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disordersJens Hillengass, Saad Usmani, S Vincent Rajkumar, et al.
Pageof 88